Last updated on October 2015

Utility of PharmacoGenomics for Reducing Adverse Drug Effects


Brief description of study

UPGRADE aims to see whether data from Pharmacogenomic Testing (PGx) can help physicians manage patient medication regimens and assess if the testing has an effect on reducing adverse drug reactions, hospitalizations and emergency department visits. The way an individual processes a drug is in part determined by their genes, and there is known to be genetic variation between humans in the way drugs are metabolized. The study of the way genes affect a person's response to drugs is known as "Pharmacogenomics."

Clinical Study Identifier: NCT02081872

Find a site near you

Start Over

Pain Medicine Physicians

Millburn, NJ United States
7.75miles
  Connect »

Vanguard Medical Group

Montville, NJ United States
8.99miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.